Schedule 13D ownership disclosure

ABIVAX SA SPONSORED ADS

Ordinary Shares, par value EUR0.01 per share · CUSIP: 00370M103

Event date: 2025-02-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sofinnova Crossover I SLPReported CIK 0001845105

    Shares: 7,794,478.00 · Class: 11.0%

  • Sofinnova Partners SASReported CIK 0001574139

    Shares: 7,794,478.00 · Class: 11.0%

  • Antoine PapiernikReported CIK 0001768408

    Shares: 7,794,478.00 · Class: 11.0%

  • Cedric Moreau

    Shares: 7,794,478.00 · Class: 11.0%

  • Kinam Hong

    Shares: 7,794,478.00 · Class: 11.0%

  • Joseph Anderson

    Shares: 7,794,478.00 · Class: 11.0%

  • Jacques Theurillat

    Shares: 7,794,478.00 · Class: 11.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014140
Form type
SCHEDULE 13D/A
Filer
Abivax S.A.
CIK
CIK 1956827
Filed
Feb 14, 2025
Reporting period
Feb 14, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub